{"PubmedArticle": [{"MedlineCitation": {"OtherID": [], "SpaceFlightMission": [], "KeywordList": [["Bisphosphonate-related osteonecrosis", "Bisphsophonate", "Comet assay", "MRONJ treatment", "Ozone therapy", "Scratch assay"]], "CitationSubset": [], "InvestigatorList": [], "OtherAbstract": [], "GeneralNote": [], "PMID": "28699091", "DateCompleted": {"Year": "2018", "Month": "11", "Day": "05"}, "DateRevised": {"Year": "2018", "Month": "11", "Day": "13"}, "Article": {"Language": ["eng"], "ArticleDate": [{"Year": "2017", "Month": "07", "Day": "11"}], "ELocationID": ["10.1007/s00784-017-2163-6"], "Journal": {"ISSN": "1436-3771", "JournalIssue": {"Volume": "22", "Issue": "2", "PubDate": {"Year": "2018", "Month": "Mar"}}, "Title": "Clinical oral investigations", "ISOAbbreviation": "Clin Oral Investig"}, "ArticleTitle": "The effects of ozone application on genotoxic damage and wound healing in bisphosphonate-applied human gingival fibroblast cells.", "Pagination": {"StartPage": "867", "EndPage": "873", "MedlinePgn": "867-873"}, "Abstract": {"AbstractText": ["Medication-related osteonecrosis of the jaws (MRONJ) is an extremely therapy-resistant disease involving the jaws especially following bisphosphonate treatment. Bisphosphonates accumulate in bone in concentrations sufficient to be directly toxic to the oral epithelium. Current therapeutic options are inadequate for the prevention and treatment of MRONJ. The aim of this study was to investigate effects of ozone gas plasma therapy on wound healing in bisphosphonate-applied human fibroblasts.", "Human primary gingival fibroblasts were cultured. Cytotoxic concentrations (IC50) of bisphosphonates (pamidronate (PAM), alendronate (ALN), and zoledronate (ZOL)) were determined by MTT test. A 60\u00a0\u03bcg/\u03bcl for 30\u00a0s of ozone gas plasma application was performed to all experimental culture flasks after drug treatment at 24-h intervals as 3\u00a0s/cm<sup>2</sup>. Genotoxic damages were evaluated by comet assay and wound healing was determined by in vitro scratch assay.", "PAM, ALN, and ZOL applications caused genotoxic damage on primary human gingival fibroblast DNA. Ozone gas plasma therapy significantly decreased the genotoxic damage (p\u00a0<\u00a00.05), and this application provided 25, 29, and 27% less genotoxic damage in order of ALN, PAM, and ZOL groups. Ozone gas plasma therapy significantly increased wound healing rates both in postsurgical 24th and 48th hours for all doses of experimental drug groups (p\u00a0<\u00a00.05).", "The ozone gas plasma application decreased genotoxic damage effect of bisphosphonate usage while improved the wound closure rate on human gingival fibroblasts.", "Ozone gas plasma therapy may be helpful in prevention of gingival healing delay in MRONJ pathogenesis especially when applied simultaneously with surgical intervention."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Oral and Maxillofacial Surgery, Faculty of Dentistry, Baskent University, Bah\u00e7elievler 11. Sokak no:26 Mare\u015fal Fevzi \u00c7akmak Caddesi \u00c7ankaya, 06490, Ankara, Turkey. sdksoydan@yahoo.com."}], "LastName": "Akdeniz", "ForeName": "S\u0131d\u0131ka Sinem", "Initials": "SS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Oral and Maxillofacial Surgery, Faculty of Dentistry, Baskent University, Bah\u00e7elievler 11. Sokak no:26 Mare\u015fal Fevzi \u00c7akmak Caddesi \u00c7ankaya, 06490, Ankara, Turkey."}], "LastName": "Beyler", "ForeName": "E", "Initials": "E"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medical Biology, Faculty of Medicine, Baskent University, Ankara, Turkey."}], "LastName": "Korkmaz", "ForeName": "Y", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medical Biology, Faculty of Medicine, Baskent University, Ankara, Turkey."}], "LastName": "Yurtcu", "ForeName": "E", "Initials": "E"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Private Practice, Ankara, Turkey."}], "LastName": "Ates", "ForeName": "U", "Initials": "U"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Oral and Maxillofacial Surgery, Faculty of Dentistry, Baskent University, Bah\u00e7elievler 11. Sokak no:26 Mare\u015fal Fevzi \u00c7akmak Caddesi \u00c7ankaya, 06490, Ankara, Turkey."}], "LastName": "Araz", "ForeName": "K", "Initials": "K"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medical Genetics, Faculty of Medicine, Baskent University, Ankara, Turkey."}], "LastName": "Sahin", "ForeName": "F I", "Initials": "FI"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Private Practice, Ankara, Turkey."}], "LastName": "Torun", "ForeName": "O Y", "Initials": "OY"}], "GrantList": [{"GrantID": "Project No: D-DA 13/02", "Agency": "Baskent \u00dcniversitesi (TR) (Baskent University Institutional Review Board and Ethics Committee)", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Germany", "MedlineTA": "Clin Oral Investig", "NlmUniqueID": "9707115", "ISSNLinking": "1432-6981"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Diphosphonates"}, {"RegistryNumber": "0", "NameOfSubstance": "Mutagens"}, {"RegistryNumber": "0", "NameOfSubstance": "Plasma Gases"}, {"RegistryNumber": "66H7ZZK23N", "NameOfSubstance": "Ozone"}], "MeshHeadingList": [{"QualifierName": ["drug therapy", "pathology"], "DescriptorName": "Bisphosphonate-Associated Osteonecrosis of the Jaw"}, {"QualifierName": [], "DescriptorName": "Cells, Cultured"}, {"QualifierName": ["toxicity"], "DescriptorName": "Diphosphonates"}, {"QualifierName": ["drug effects"], "DescriptorName": "Fibroblasts"}, {"QualifierName": ["cytology"], "DescriptorName": "Gingiva"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "In Vitro Techniques"}, {"QualifierName": [], "DescriptorName": "Mutagenicity Tests"}, {"QualifierName": ["toxicity"], "DescriptorName": "Mutagens"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Ozone"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Plasma Gases"}, {"QualifierName": ["drug effects"], "DescriptorName": "Wound Healing"}]}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Clin Oral Investig. 2010 Feb;14(1):35-41", "ArticleIdList": ["19294435"]}, {"Citation": "J Craniomaxillofac Surg. 2012 Dec;40(8):e229-35", "ArticleIdList": ["22082730"]}, {"Citation": "J Periodontol. 2016 Aug;87(8):982-9", "ArticleIdList": ["26991488"]}, {"Citation": "J Periodontal Res. 2015 Feb;50(1):37-43", "ArticleIdList": ["24665871"]}, {"Citation": "Interv Neuroradiol. 2014 Oct 31;20(5):632-6", "ArticleIdList": ["25363268"]}, {"Citation": "J Craniofac Surg. 2007 Sep;18(5):1068-70", "ArticleIdList": ["17912084"]}, {"Citation": "Int J Dent. 2014;2014:107690", "ArticleIdList": ["24648841"]}, {"Citation": "J Craniofac Surg. 2007 Sep;18(5):1071-5", "ArticleIdList": ["17912085"]}, {"Citation": "Pharm Biol. 2014 Nov;52(11):1374-81", "ArticleIdList": ["25026350"]}, {"Citation": "Clin Oral Investig. 2012 Feb;16(1):87-93", "ArticleIdList": ["21225298"]}, {"Citation": "J Oral Maxillofac Surg. 2011 Oct;69(10 ):2564-78", "ArticleIdList": ["21807448"]}, {"Citation": "Clin Oral Investig. 2010 Feb;14(1):51-8", "ArticleIdList": ["19597852"]}, {"Citation": "Arch Oral Biol. 2011 May;56(5):491-8", "ArticleIdList": ["21146154"]}, {"Citation": "Eur Rev Med Pharmacol Sci. 2012 Nov;16(12):1741-7", "ArticleIdList": ["23161050"]}, {"Citation": "Mediators Inflamm. 2004 Feb;13(1):3-11", "ArticleIdList": ["15203558"]}, {"Citation": "Br J Haematol. 2005 Mar;128(6):738", "ArticleIdList": ["15755276"]}, {"Citation": "Haematologica. 2007 Sep;92(9):1289-90", "ArticleIdList": ["17768133"]}, {"Citation": "J Periodontol. 2016 Jun;87(6):663-71", "ArticleIdList": ["26777769"]}, {"Citation": "Hum Exp Toxicol. 2015 Nov;34(11):1073-82", "ArticleIdList": ["25636638"]}, {"Citation": "Br J Biomed Sci. 1999;56(4):270-9", "ArticleIdList": ["10795372"]}, {"Citation": "J Dent. 2008 Feb;36(2):104-16", "ArticleIdList": ["18166260"]}, {"Citation": "Hum Exp Toxicol. 2014 Dec;33(12):1269-76", "ArticleIdList": ["24677352"]}, {"Citation": "Mycoses. 2002 Oct;45(8):329-32", "ArticleIdList": ["12572723"]}, {"Citation": "Evid Based Complement Alternat Med. 2004 Dec;1(3):315-319", "ArticleIdList": ["15841265"]}, {"Citation": "Wien Med Wochenschr. 2016 Feb;166(1-2):68-74", "ArticleIdList": ["26847441"]}, {"Citation": "Int J Oral Maxillofac Surg. 2014 Jun;43(6):777-83", "ArticleIdList": ["24491848"]}, {"Citation": "J Contemp Dent Pract. 2008 May 01;9(4):75-84", "ArticleIdList": ["18473030"]}, {"Citation": "J Craniofac Surg. 2006 Nov;17(6):1080-3", "ArticleIdList": ["17119409"]}, {"Citation": "J Oral Maxillofac Surg. 2005 Nov;63(11):1567-75", "ArticleIdList": ["16243172"]}, {"Citation": "Oral Oncol. 2011 Mar;47(3):185-90", "ArticleIdList": ["21310650"]}, {"Citation": "Caries Res. 2000 Nov-Dec;34(6):498-501", "ArticleIdList": ["11093025"]}, {"Citation": "Eur Arch Otorhinolaryngol. 1999;256(3):153-7", "ArticleIdList": ["10234486"]}, {"Citation": "Free Radic Biol Med. 2000 Oct 1;29(7):612-9", "ArticleIdList": ["11033413"]}], "ReferenceList": []}], "History": [{"Year": "2016", "Month": "12", "Day": "13"}, {"Year": "2017", "Month": "6", "Day": "23"}, {"Year": "2017", "Month": "7", "Day": "13", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "11", "Day": "6", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "7", "Day": "13", "Hour": "6", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["28699091", "10.1007/s00784-017-2163-6", "10.1007/s00784-017-2163-6"]}}], "PubmedBookArticle": []}